A BOTANICAL STORY FROM NANTES · DOCUMENTARY EDITION
tosma✳
UNDERSTAND · CHOOSE · MOVE FORWARD

Quit-smoking medicines: what to discuss with a clinician.

Some medicines address dependence without supplying nicotine. Choosing one requires a clinical assessment rather than a promise of success.

A treatment option, not a shortcut.

A medicine may reduce withdrawal or change the reward associated with smoking. It does not decide how you will handle breaks, social situations or routines that need rebuilding. Discussing daily life remains useful when a prescription is being considered.

A clinician needs to know about your current medicines, previous side effects, health history and preferences. Two people smoking the same number of cigarettes can need different approaches. Bring a record of earlier treatment rather than relying on memory alone.

Four stages of a clinical decision.. Before: History and current medicines. Choose: Expected benefit and precautions. During: Tolerance and difficult situations. Review: Progress and the next steps
This diagram does not specify a medicine, dose or duration.

Recommendations do not establish local access.

An international recommendation does not mean a medicine is authorised, available or reimbursed in every country. The table prepares questions for a consultation; it does not recommend a purchase, dose or drug combination.

OptionGeneral approachDecision point
VareniclineActs at nicotinic receptorsPrescription, tolerability and follow-up
BupropionA non-nicotine cessation medicineContraindications and interactions
Cytisine / cytisiniclineAnother studied cessation optionApproval and access vary between countries
Nicotine replacement therapyNicotine delivery without smokeFormulation, technique and withdrawal coverage
Accompanying supportPlanning and managing situationsAccessible follow-up and shared goals

Options recognised by the WHO.

The WHO’s 2024 clinical guideline identifies nicotine replacement therapy, varenicline, bupropion and cytisine as pharmacological options for adults who want to stop smoking. It also recommends behavioural support. This framework supports discussion rather than providing an individual prescription.

French health-insurance guidance describes varenicline and bupropion as medicines requiring medical supervision. Precautions, interactions and potential side effects must be considered before treatment is chosen.

Prepare questions, not a product request.

Ask why the option suits your circumstances, which effects mean you should contact the clinician, when progress will be reviewed and what to do if you still smoke during the attempt. Write down the answers so you do not have to reconstruct them during a difficult moment.

After several attempts, describe what happened rather than simply writing “failed”. Stopping because of an adverse effect, using a medicine incorrectly and lacking support are different problems. Do not alter a prescription on your own or borrow someone else’s treatment.

Useful questions

Is the most effective medicine on average always best for me?

No. Average results must be considered alongside contraindications, tolerability, availability and your preferences.

Can I take a relative’s treatment?

No. Prescribing and follow-up are individual.

General information for adults, not a substitute for medical advice. Treatment selection, dose and duration should be agreed with a healthcare professional. Pregnancy, breastfeeding, age under 18 or significant illness require tailored support.